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PROTEIN STUDIES IN SCLERODERMA
CO TUT, M.D.* N. H. KUO, M.D.f AND S. SIMUANGCO, M.D4
WITH TECHNICAL ASSISTANCE or LILLY SCHMIDT AND THE LABORATORIES OF TEE
MALTINE COMP.
This is the report of preliminary studies on:
1. The protein metabolism in scieroderma and
2. The effect of a hyperproteinization regimen on the condition.
The clinical material consists of 4 cases of scleroclerma, the relevant points in
whose history and physical examination appear in Table I and whose pertinent
laboratory data are recorded in Table II.
There were three females and one male; three white patients and one Negro.
The ages ranged from 27 to 63 years, the duration of the disease from 1 to 20
years. There was history of weight loss in two. The areas and intensity of in-
volvement, tabulated in Table II appear graphically in Figs. la, 2a, 3a an 4a.
The diagnosis was diffuse scleroderma in three and localized in one, all the dif-
fuse cases being accompanied by Raynaud's phenomenon.
In an attempt to appraise the degree of induration on a semi-objective basis,
4 degrees of induration were arbitrarily adapted in both Table I and the figures
as follows:
DKSCRIPTION OF PARTS SYMBOL IN TARLE MARKING IN FIGS.
Acroscierotic (horny, cold, blanched)
Hard leather
Soft leather
Parchment-like
A
ilL
SL
P
Black
Striped
Stippled, heavy
Stippled, light
This classification is merely tentative and no brief is here held for its general
adoption.
The degree of induration and the extent of involvement seems to be roughly
proportional to the duration of the disease, the order being; L. A. 20 years, M.
Mc. 3 years, P. W. and A. K. one year.
The laboratory findings (Table II) are not significant. There did not appear
to be any of the characteristic changes of protein depletion as observed by Molli-
son et al. (1) by others (2—4) in cases of starvation and by ourselves in cases of
protein depletion following disease (5). The changes observed in such frank
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PROTEIN STUDIES IN SCLERODERMA
SCLERODERMC AREAS OF PW' ON 22O47
BEFORE 4YPERPROTE,r4IZATION.
• ACROSCLEJ?OTIC
•HARD LEATHER
- SOFT
- PARCHMENT-LI<E
185
cases of protein depletion were high relative plasma volume (hyperplasmovo-
lemia) and thiocyanate space (extracellular space or thiocyanate space) when
$CLERODEPMJC AREAS OF PW0N 6-25-47,
OR TER Hi PAYS OF HYPERPROTEINIZATION.
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the patients were ambulatory as were these four cases; and sometimes a low
hematocrit and total plasma proteins, particularly plasma albumin. The blood
calcium was slightly higher than normal in M. Mc. and A. K. in whom this test
was performed, and there was osteoporosis in L. A., which accompanies but is not
pathognomonic of protein depletion. No roentgenograph of the bones was taken
of the other cases.
In addition to the laboratory study, the protein studies consisted of nitrogen
balance during a period of 4 to 11 days on a routine ward diet called hereinafter,
the "control" period and during a period of from 4 to 11 days on the hyperpro-
teinization regimen. After the period of N-balance, the hyperproteinization regi-
men was continued as long as was practicable under the circumstances surround-
ing each particular patient. However, owing to the unappetizing taste of most of
the hyperproteinization agents and the expense and trouble involved as well as
the monotony of taking a particular substance for a long period of time, it is
impossible to vouch how faithfully the patients adhered to the regimen after they
were discharged from the hospital. Two of the patients, A. K. and M. Mc. were
placed on 14 tablets of protein hydrolysate (Nitramac) daily containing alto-
gether 25.4 gm of protein as supplement to their diet during the last 2 months of
their regimen. The body weight and the changes occurring in the involved areas
were noted periodically, as were also, at least for a short period of time, some of
the laboratory parameters.
As indicated in Table I, all the patients, except A. K. had previous treatments.
P. W. had courses of dihydrotachysterol, priscol and bilateral sympathetic
block without perceptible effect. L. A. had in the course of 20 years, vitamin D,
bilateral sympathectomy, fever therapy and roentgenotherapy to her hands and
M. Mc. vitamins E, A and B6.
The nitrogen balance records during both the control and the hyperproteiniza-
tion periods appear in Tables III to VI.
Nitrogen balance during control periods
The basic protein intake recommended by the National Research Council (6)
for support of protein nutrition in the normal subject is 70 grams daily or 1
gm/kgm. In terms of N, this is 11.2 gm per individual or 0.16 gm/kgm; and is
perhaps twice the minimum requirement. The daily total urinary N excretion
(DTIJN) at this level of intake rarely exceeds 10 gms daily which is significantly
lower than the 11.3 gm (7) found for the average of the general population on an
unrestricted diet. The Bellevue Hospital patient who is not acutely ill and has
no special nursing attention is offered from 9.14 gm to 14.5 gm of N daily and on
this intake during the short periods in which N balances were studied, the DTUN
almost never exceeds 9 gms resulting in a positive N balance of from 1 to 4 gms.
These values incidentally reveal the low nutritional margin in which the patients
from the lower economic strata subsist.
With the above data as basis, the metabolic records of these 4 patients during
the control periods may be examined.
P. W. during the 11 control days (Table Ill-A) was taking from 11.4 (2/23)
PROTEIN STUDIES IN SOLERODERMA 187
TABLE III
Nitrogen balance record
Name: P. W. Diagnosis: Scieroderma—diffuse.
DATE GRIN. VOL.
CAL/KBW NITROGEN INTAKE NITROGEN OUTPUT
nw/Rem
Unit Food NISUp.* NTotal N Urin. NjFecal NjTotal N Total N
Part A
2/18
2/19
2/20
2/21
2/22
2/23
2/24
2/25
2/26
2/27
2/28
cc
1500
1800
1300
1950
1560
1850
1300
1280
1600
1250
800
51
52
50
55
50
55
52
50
55
50
54
gns.
13.51
16.12
18.26
11.58
18.85
11.4
14.12
14.09
11.66
17.13
14.21
gms. gms. gms. gms.
13.49 1.17
9.88 1.17
10.17 1.17
11.84 1.17
10.37 1.17
11.66 1.17
11.23 1.17
12.25 0.66
10.08 0.66
18.24 0.66
10.93 0.66
gms.
14.66
11.05
11.34
13.01
12.54
13.83
13.40
12.91
10.74
18.90
11.59
—1.15
+5.07
+6.92
—1.43
+6.31
—2.43
+0.72
+1.18
+0.92
—1.77
+2.62
58.9
57.9
Total N intake from 2/18 to 2/28 152.93
Average N intake 13.9
Total N retained +3.62
Average N retained +0.36
Part B
3/1
3/2
3/3
3/4
3/5
3/6
3/7
3/8
3/9
3/10
3/11
1400
2000
1975
1625
1875
1820
1700
1800
1575
1520
1900
55
50
50
55
50
50
50
55
50
50
50
13.96
10.19
12.7
11.26
13.92
18.56
13.76
16.48
19.58
13.96
20.22
34.8
34.8
34.8
31.68
34.88
34.8
34.8
34.8
34.8
31.68
34.8
48.76
44.99
47.5
42.94
48.72
53.36
48.56
51.28
53.30
45.64
55.02
18.14
13.08
28.36
22.00
24.53
20.00
21.83
27.32
19.50
19.17
24.85
1.25
1.25
(1.25)
7.52
1.25
1.25
1.25
(1.59)
2.18
1.59
1.59
(1.59)
5.77
1.59
19.39
14.33
30.61
23.25
25.78
21.15
23.42
28.91
21.49
20.76
26.44
+29.37
+30.66
+16.89
+19.69
+22.94
+32.21
+25.14
+22.37
+32.81
+24.88
+28.58 60.2
Total N intake from 2/18 to 3/11 541.15
Average N intake 49. 2
Total N retained.... +285.54
(0.85 gm/kgm)
-
Nitrogen retained 285.54 52 48Nitrogen intake 541.15
*Supplementary nitrogen in form of protolysate.
to 18.85 gm of N daily (2/20), a total of 152.93 gm N for the entire period or an
average of 13.9 gm daily, with a caloric intake maintained at from 50 to 55 per
kgm. per day, calculated according to the original weight of 58.9 kgm. During
those days, the urinary nitrogen ranged from 9.88 (2/19) to 18.24 (2/27) gms,
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all DTUN values being over the average Bellevue level found in non-acutely ill
cases. The noteworthy values are an excretion of 13.49 (2/18), 11.84 (2/21),
11.66 (2/23), 10.08 (2/26) and 18.24 (2/27) for intakes of 13.5, 11.58, 11.4, 11.66
and 17.13 gms respectively. During those 11 days, he had an over-all apparently
positive N balance of 3.62 gm or an average of 0.36 gm daily, which was perhaps
TABLE IV
Nirogen balance record
Name: L. A. Diagnosis: Seleroderma—diffuse.
DATE WT. VOL.
CAL/BW NITROGEN INTAXE NITROGEN OVTPUT
Unit Food NjSup.* NiTotal N Urin. NiFecal NiTotal N TotAl N
Part A
6/20
6/21
6/22
6/23
6/24
6/25
6/26
kgtns.
54.56
54.32
cc.
1550
2100
1250
1150
1400
[800
825
52
41
45
15
13
11
16
gins,
14.55
13.37
14.36
2.63
3.28
3.54
3.74
gins. gins. gms.
10.14
10.29
11.68
6.18
6.22
6.30
9.25
gins.
1.56
1.56
1.56
1.56
1.56
1.56
1.28
gms.
11.70
12.85
13.24
7.74
7.78
7.86
10.53
+2.85
+1.52
+1.12
—5.11
—4.5
—4.32
—6.79
Total N intake from 6/20 to 6/23 42.28
Average N intake 13.98
Total N retained.... 5.49
Average N retained. +1.83
Part B
6/27
6/28
6/29
6/30
7/1
7/2
7/3
7/4 57.25
1020
1000
1000
1200
800
1100
1050
1200
50
55
50
50
50
55
55
55
3.83
2.23
2.94
1.03
3.42
6.91
4.73
8.7
21.76
19.67
28.76
21.76
10.3
21.76
30.74
23.06
25.59
21.90
24.70
22.79
13.72
26.67
35.47
31.76
9.05
12.96
12.14
15.97
12.14
12.33
11.77
16.25
5,4
5.4
5.4
5.4
0.59
0.59
0.59
0.59
14.45
18.36
17.54
21.37
12.73
12.92
12.36
16.84
+11.14
+3.54
+7.16
+1.42
+.99
+15.75
+23.11
+14.92
Total N intake from 6/27 to 7/4 198.60
Average N intake 24.82
Total N retained 78.03
Average N retained.. 9.68
(0.46 gm/kgm)
Nitrogen retained 78.03
Nitrogen intake 198.60
* Supplementary nitrogen in form of "Lactenz."
in fact negative. He was in frankly positive balance on 5days, (Feb. 19, 20,22,25,
and 28). On 4 days (Feb. 18, 21, 23, and 27), he was in frankly negative balance.
The DTUN exceeded the intake N in almost all the days except one when they
were practically identical. It thus appears that even in the presence of caloric
and nitrogen adequacy, a state of negative balance existed and that this was due
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more to the large DTUN which significantly exceeded the Bellevue maximum
than to any other factor. During the remaining part of the control period, there
were two days (Feb. 24 and 26) when the nitrogen balance was borderline and
perhaps negative, being +0.72 and +0.92 gm respectively.
In the diet of L. A. (Table TV-A), during the last 4 control days (June 23 to
26) there was unfortunately an inadequate N and caloric intake resulting in nega-
tive N balance. These 4 days must therefore be excluded from consideration in
TABLE V
Nitrogen balance record
Name: M. Mc. Diagnosis: Scieroderma.
DATE WT. VOL.
CAL/KBW NITROGEN INTAKE NITROGEN OVPUT TG
Unit Food NlSup.* NTotaI N Urin. NiFecal NTotal N Total N
Part A
4/30
5/1
5/2
5/3
kgms.
45
45.54
cc.
1621
1475
1040
1665
55
56
50
54
gms.
14.43
11.84
12.52
16.5
gms. gms. gns.
8.36
8.73
10.74
9.07
gms.
1.61
1.61
1.61
1.61
gms.
9.97
10.34
12.35
10.68
+4.45
+1.50
+.17
+5.82
Total N intake from 4/30 to 5/3 55.92
Average N intake 13.82
Total N retained 11.95
Average N retained... 2.96
Part B
5/4
5/5
5/6
5/7
1815
1650
2160
2765
50
55
50
55
16.81
14.68
12.57
13.23
20.52
20.52
20.52
11.48
37.33
35.20
33.09
24.71
10.97
12.64
12.99
17.45
1.45
1.45
1.45
1.45
12.42
13.09
14.44
18.90
+24.91
+22.11
+18.65
+5.81
Total N intake from 5/4 to 5/7 130.33
Average N intake 32.77
Total N retained... 71.48
(0.74 gm/kgm)
Nitrogen retained 71.48
Nitrogen intake 130.33
* Supplementary nitrogen in form of Provimalt.
the study of metabolism inherent to the disease. On the first three days of the
control period (June 20 to 22), however, both caloric and nitrogen intakes were
adequate, being 52, 41 and 45 calories per kgm. and 14.55, 13.37 and 14.36 gm
N respectively. While the tendency to hyperazoturia is not quite as clear here as
in the case of P. W., the DTTJN of respectively 10.14, 10.29 and 11.68 gm N were
significantly above the upper limit, so that it cannot be said to be conclusively
absent.
Of the two remaining cases, M. Mc. (Table V-A), the hyperazoturic tendency
was found on only one day, May 2, when on an intake of 12.52 gm nitrogen, there
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was a DTUN of 10.74 gm resulting in a borderline N-balance of +.17 gm
which was almost certainly negative. A. K. (Table VT-A) showed hyperazoturia
in 2 of the 4 days during the control period, DTIJN being 13.03 gm N for an in-
take of 13.76 gm for April 30 and of 14.47 gm for an intake of only 10.55 on May
1. On both of these days, the N-balance was negative.
As will be noted, the tendency to hyperazoturia in the ftrst of the two cases is
not steady, but fluctuates from day to day. Whether azoturia is caused or effect
is not clear. If a scierodermatous condition can extend to such visceral organs as
the gastrointestinal tract (7), to the heart (8) and the lungs (9, 10), it would seem
TABLE VI
Nitrogen balance record
Name: A. K. Diagnosis: Seleroderma, localized.
DATE
VEIN.
VOL.
CAL/RBW
Unit
NITROGEN INTAKE
Food NjSuP.* NTotal N
NITROGEN OUTFOT
Urin. NiFecal NiTotal N
NITROGEN
BALANCE
Total N
Part A
4/30
5/1
5/2
5/3
kgms.
63.86
64.54
cc.
2755
2625
1275
1765
51
52
50
51
gms.
13.76
10.55
15.74
16.33
gms. gms. gms.
13.03
14.47
10.95
12.10
ems.
0.81
0.81
0.81
0.81
gms.
13.84
15.28
11.76
12.91
—0.08
—4.73
+3.98
+3.42
Total N intake from 4/30 to 5/3 56.38
Average N intake 14.01
Total N retained... +2.61
Average N retalned .. -(. .65
Part B
5/4
5/5
5/6
2375
1630
2022
.50
53
50
16.32
14.84
14.79
27.36
21.45
17.10
43.68
36.29
31.89
13.16
18.07
22.12
1.03
1.03
1.03
14.19
19.10
23.15
+29.49
+17.19
+8.74
Total N intake from 5/4 to 5/6 111.86
Average N intake 37.29
Total N retained 62.42
(0.57 gm/kgm)
Nitrogen retained — 62.42
— 8Nitrogen intake — 111.86
* Supplementary nitrogen in form of Provimalt.
probable that the kidneys might also be involved and this azoturia might be due
to interference with renal reabsorption of amino acids.
Fecal nitrogen
Because of the possibility that involvement of the gastrointestinal mucosa
might affect the absorption of nutrients, the ratio of fecal nitrogen to the intake
nitrogen during this control period was determined.
Aibright et al. (11) in a study of the fecal nitrogen at 33 different levels of nitro-
gen intake has established a valuable basis for comparison. Part A of Table VII
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shows that during the control period, P. W., M. Mc., and A. K. on an intake
of 152.93, 55.92 and 56.38 gm of N, were excreting respectively, 9.83, 6.44 and
FecaiN3.24 gm of fecal nitrogen showing a Intake N respectively of 6.4, 11.5 and 5.7%.
These values are either at or below the Albright values at this intake level. L. A.
Fecal Nhowever, on an intake of 42.28 gms % of N, excreted 9.36 gms with aIntake N
of 21.7% and suggesting a markedly decreased N-absorption. The possibility
of this decreased absorption being due to a sclerotic process affecting the ab-
sorptive areas is supported by the fact that she had dysphagia.
During the hyperproteinization period, (Table Vu-B), while P. W., M. Mc.
and A. K. had a fecal N/Intake N of respectively only 2.8, 4.5 and 2.8%, L. A.
had a ratio of 12%, strongly supporting the suspicion that the absorptive power
TABLE VII
fecal nitrogenRatios of in four cases of scierodermaintake nitrogen
PATIENT NO. OP STUDY DAYS TOTAL N INTAKE TOTAL PECAL N FECAL NGM GM INTAKE N
Part A. Control Period
P. W ii
L.A 7
M.Mc 4
A. K 4
152.93
42.28
55.92
56.38
9.83
9.36
6.44
3.24
%
6.4
21.7
11.5
5.7
Part B. Hyperproteinization Period
P.W 11 541.15
L.A 8 198.6
M. Mc 4 130.33
A.K 3 111.86
15.45
23.96
5.8
3.09
2.8
12.
4.5
2.8
of the gastrointestinal tract, at least for proteins was adversely affected. This
may also account for her impaired appetite.
At this point, it may be relevant to point out that the nitrogen balance is not
reliable in the study of conditions in which the loss is so small as to be blanketed
out by the large experimental error resident in the method. This has been amply
discussed elsewhere (12). Thus if a person loses 0.75 gm N daily for say 6 months,
the total loss to the body during this period would be 135 gm N or 844 gm of
protein, and yet the nitirogen balance study would perhaps register a positive
balance throughout the study. Thus in cancer and tuberculosis and n all slow
wasting diseases, the daily lbss may be imperceptible.
Nitrogen balance during the hyperproteinization period
The term hyperproteinization as has been discussed before (5), is applied to a
dietetic regimen whose protein intake is as large as can be ingested with a caloric
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intake of from 45 to 50 calories/KBW in the form of a simple carbohydrate as
dextrine. It is usually from 2 to 5 times that of the traditional "high protein
diet" of 120 gms protein daily. The term hyperproteinization is used advisedly
sharply to distinguish between the two regimens, which differ so much both
quantitatively and in their effects. In our work with protein depletion, it was
found that with such a regimen, a greater amount of protein deposition is made
possible than by the use of traditional diets, with correspondingly larger increases
in body weight and strength. The rationale and philosophy of the regimen has
been discussed elsewhere (5, 12, 13).
The hyperproteinization agents used were, Protolysate for P. W., Lactenz for
L. A. and Provimalt for both A. K. and M. Mc. Both Protolysate and Lactenz
are protein hydrolysates, one of casein containing 12% nitrogen and the other
of lactalbumin with 11% nitrogen. Provimalt is a whole milk protein containing
9% nitrogen.
P. W. during the 11 days of nitrogen balance study under hyperproteinization
(Table 111-B) on a total daily intake varying from 42.94 (3/4) to 55.02 gm (3/11)
and an average per kgm daily intake of 0.85 gm/kgm retained from 16.89 (3/3)
to 32.31 gm N (3/9). The total nitrogen retention was 285.54 gin on a total in-
take of 541.15 gm nitrogen during the 11 days. This means a retention of 52.48%
which is a response characteristic of protein depletion. Similarly, L. A. (Table
TV-B) on an intake of 0.46 gm/kgm, retained 39.3%; M. Mc. (Table VT-B) on
an average daily nitrogen intake of .74 gm/kgm, 54.84% and A. K. (Table V-B),
on an average daily nitrogen intake of .57 gm/kgm, 55.8%. The weight gains
were from 57.9 to 62.3 kgm in one month to 62.9 kgm in 117 days for P. W.;
from 54.32 to 57.75 kgm in 15 days for L. A.; from 45.54 to 47.5 kgm in 26 days for
M. Mc. and from 64.54 to 66.82 in 32 days for A. K. These findings suggest a
well-developed "protein hunger."
Other effects of hyperproteinization
The laboratory parameters followed serially during the hyperproteinization
regimen were also included in Table II in the horizontal columns under the initial
findings. They showed no significant changes.
The clinical parameters were: 1. Healing of superficial ulcers; 2. Softening of
the involved parts; 3. Changes in the hair; 4. Flexibility of the joints, and 5.
Subjective symptoms.
These points will be discussed seriatim.
Ulcers
P. W. and L. A. had ulcers over the dorsal surface of the interphalangeal joints.
These were healed in respectively 3 weeks and one month.
Softening of the parts
As may be seen from Figs. lb, 2b, 3b, and 4b, in all the cases there were changes
in the softness of the involved parts, the parchment-like area over the sternum
of P. W. disappearing altogether, while most of the soft-leather-like parts be-
came parchment-like and a large area of the hard leathery-parts becoming soft-
leathery. The acroscierotic parts however, underwent the least changes, some
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SCLERODERMIC AREAS OF L.A: OW 9-17-47.
OR AFTER 8OAVS OF HYPERPROTEJNJZATION.
such areas becoming hard leathery, but other parts specially in the fingers re-
maining unchanged.
- SCLEROOERMIC AREAS OF LAON 6-l5-47 -
SEFORE HYPE1PROTENIZATJOPJ.
ACRO5CLEROTIC
- HARE L.EAThER
W-5OFT LEATHERt-pARcHHEwT- L1E
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SCLERODeRM,c AREAS OF M.MC 0. ON 4-28-46.
BFFORE HYPERPROTg,N,ZATION.
ACRO5OEROTC
- -*ARO LEATI-1ER
- SOFT L.ETFfE.R.
- PCHNT-UKE
Another method of gauging the softness of the involved parts was by measure-
ment with an instrument constructed on the principle of an optical tonometer.
SCLERODERMIC AREAS OF 'M.MCD. ON 6-7-49, OR
AFTER 65 OAY5 OF tYPERPROTEJNIZATION.
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SCLERODERMIC AREAS OF A.K ON 9j-q9 AFTER
S2 0AY5 Of HYPERPROTE,NZATI0N.
Fig. 5 is a schematic drawing of the instrument. It consists of a cylinder A,
3 inches long having an internal diameter of inch. The cylinder is connected
with a horizontal rod B which is held fast by a clamp to a vertical part E mounted
•SCLERODERMIC AREAS O A ON 5-548 BEFORE
UYPERPROTRINZATION.
FIG. 4-8
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on a rigid support. Closely fitting into the cylinder and sliding in it without play
and with minimum friction is piston C, C' and C2. The upper end of the piston
extends beyond the upper rims of the cylinder for about 2 inches. The lower por-
tion of this part of the piston C' is divided into 60 equal divisions so marked that
when the lower end of the piston C2 is flush with the lower rim of the outer cylin-
der, the "0" mark of the calibrated section is just flush with the upper rim of the
cylinder. On the top of the piston is weight pan "D" on which weights are placed.
To take readings of the softness of tissues, the lower ends of the pistons and
cylinder are lowered to rest on the surface of the part and clamped on in this
FIG5
tISSUE TONOMETER
c, -Wr!c
Il ._______________ I
A- CYLINDER.
B-HOLDER ATTACHED TORING STAND.
C- PISTON.
C, - CALIBRATED PART OF PISTON.
C- LOWER PARTOF PISTON PRESSINGON SKIN.SURFACE.
P - PAN FOR WEISHTS.
E- RING STAND.
TABLE VIII
Tissue tonomstric readings (700 gras)
Name: P. W.
REGION NUIEBEII DIVISIONS
2/20/47 (INITIAL)
DIVISIONS
.________________
5/23/47 (86 DAYS H')
1. Right mid-arm anterior
2. Right mid-forearm anterior
3. Left mid-arm anterior
4. Left mid-forearm anterior
12
11
13
9
18
17.5
17
19
* il—Hyperproteinization.
position. The "0" mark of the calibrated portion of the piston "C" is now op-
posite the upper rim of the piston. Weights are now added on the weight pan
"D", depressing the piston which sinks into the tissues and the depression is
read off in the calibration in C'.
As shown in Table VIII, in P. W. whose hyperproteinization started on March
1, there was improvement in all the 4 regions tested, ranging from a minimum of
4 divisions in region 3 to 13 divisions in region 4. Likewise, L. A. (Table IX)
whose hyperproteinization regimen started in June 27 and who was tested after
12 days showed marked improvements in points 3, 4 and 10, slight to moderate
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TABLE IX
Tissue tonometric readings (700 gms)
Name: L. A.
DIVISIONS DIVISIONS DIVISIONS
REGION NDI&3EE
6/16/47 (INITIAL) 7/9/47 (12 os H)" 9/24/47(89n.&ysH)*
1. Right mid-thigh anterior 10 16 14
2. Left mid-thigh anterior 9 14 27.5
3. Left thigh posterior (knee flexed at right
angle) 17 31 27
4. Right thigh posterior (knee flexed at
right angle) 18 36
5. Right leg posterior 14 29
6. Left leg posterior 10 27 33
7. Right upper arm anterior (elbow held
at right angle) 9 9 14
8. Right forearm anterior (elbow extended). 10 6 14
9. Left upper arm anterior (elbow flexed at
right angle) 9 9 16
10. Left forearm anterior (elbow extended).. 7 3 21
* fi—Hyperproteinization.
FIG. 6
OUTLINES ATMAXIMUN FLEXON ON °P.W"
2- 27-47 4-21-47 6-29-47
AFTCR52PAYSOF AFTER lIZ DAYSOF
HYPERPROTEINIZATION I-IYPERPROTEINIZATION
FIG. 7-A FIG. 7B
FINGER OUTLINES OF 'L.A. FINGER OUTLINES OF "L.A.'ON 6-15-47, BEFORE ON 10-14-47, AFTER 110 DAYS
HYPRPRO1F1NIZPTION. OF I-IYPERPROTEINIZATION,
improvement in points 1, 2 and 5, no significant improvement in points 7, 9 and
10, and even greater induration in point 8. After 89 days, regions 1 and 3 showed
no further improvement, in fact slight retrogression from the 12th day test, while
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all the others were further improved, including those that showed no improve-
ment in the 12th day test.
Changes in hair growth
The hairs of the dorsal aspect of the forearms were observed initially to be
lusterless and sparse in P. W. and M. Mc. Within the first month they became
more luxuriant and longer and more lustrous.
Flexibility of involved joints
The outlines of the fingers of both P. W. and L. A. were traced on paper ini-
tially and subsequent to hyperproteinization. As shown in Figs. 6 and 7 there
was increased flexibility in P. W. in 53 days and even more in 113 days, and
slight increase in the flexibility of the index finger of both the right and left
hands of L. A. after 122 days, but no increase in the other fingers.
Subjective sensations
All the patients felt better and "looser" after the first two weeks of hyper-
proteinization, with warmer extremities. After a period of one month, L. A. who
was at first unable to work as a domestic, was able to resume her work with a
satisfactory degree of efficiency.
COMMENTS
Were these four cases suffering from protein depletion? Although they had
none of the laboratory features commonly associated with this deficiency as it is
commonly encountered following starvation or disease, all four deposited a large
amount of protein and gained significantly in weight under a hyperproteinization
regimen, indicating a well developed systemic protein "hunger."
But to accept these cases as cases of protein depletion, would imply the exist-
ence of three types of this deficiency instead of two as have been recognized here-
tofore. These two are first, the type of depletion usually associated with starva-
tion and disease, such as have been described by Morrison et al. (1) and others
(2—5) in victims of starvation in the course of or following disease. The common
features in this first type of cases are acute weight loss, decreased body girths,
shrinkage of internal organs, thinning out of tissues and a disturbance in water
metabolism expressed as a relative hyperplasmovolemia, relative extracellular
fluid increase during activity and loss of this excess fluid after a period of rest.
These disturbances in water metabolism indicate a greater capacity of the body
to store water. The bematocrit and plasma protein levels may be maintained for
some time and in fact, the ratio of total red cell mass and total circulating plasma
proteins to the body weight is usually much higher than in the normal subject,
signifying the operation of some hemostatic mechanism keeping up the levels
of these two elements in spite of loss of body substance.
The second well recognized type of protein depletion is seen in Gushing's
disease where the protein loss is due, according to Aibright (14), to the inability
of the body to anabolize proteins and deposit tissue proteins because of the action
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of an adrenal cortical hormone, perhaps identical with or related to cortisone or
compound F. One feature of this disease which Albright has particularly stressed
is the thinning out of the tissues. The blood constituents and fluid compartments
have not received sufficient study. Nor has the effect of hyperproteinization been
explored. It is here postulated that the protein depletion associated with sclero-
derma would now constitute a third type. In tIüs view, a deficiency of proteins
of minimal degree, but existing over a prolonged period of time—a state of pro-
longed protein attrition—exists in the sclerodermic, so that the body cannot
maintain its chemical integrity and has had to substitute collagen and calcium for
its normal components. The further assumption must be made that while in the
first type of protein depletion, the loss was too rapid for the body to compensate
for the consequent disturbance in water metabolism, in the scierodermic type
this compensation had time to take place. In this light then, the high percent-
age of calcium (8) found by Combleet and Struck (15) would not be due primarily
to an error in calcium metabolism. Such an assumption would also explain why
the simple use of a hyperproteinization regimen is enough to reduce the indura-
tion of the involved tissues.
The reversibility of this induration may have another important implication
in the turnover of tissue proteins and ultimately in the maintenance of healthy
tissues. It suggests that the rise of the potential of protein nutrients in the blood
caused by hyperproteinization, forces a larger tissue protein turnover at least in
pathologic tissues. This may be at apparent variance with the work of Ritten-
berg on normal tissues (16), but not necessarily so in view of 2 considerations:
the much higher protein intake in the hyperproteinization regimen and the fact
that the tissue involved is abnormal.
If simple protein attrition is the ultimate cause of scleroderma then one would
expect to find not one but multiple conditions leading to the development of this
sclerotic condition. Any condition which causes protein attrition for prolonged
periods should bring about this condition. The attrition could result from the
smallness of the quantity of proteins ingested, in disturbances of absorption, in
increased protein catabolism, in increased nitrogen excretion or in decreased renal
reabsorption.
How does the introduction of this protein hypothesis affect the existing theories
on the etiology of this disease and on existing methods of therapy?
Leriche's theory of vasomotor causation (17) has led to the use of sympathec-
tomy. The consensus (12, 13) is that while vasomotor reaction may play a role,
it is not primary in the disease and that sympathectomy is not a treatment of
choice and even seems to hasten the progress of the disease (19, 20).
Cornbleet and Struck 15) on the basis of finding a higher content of calcium
in the selerodermatic skin than in the normal attributed the development of this
condition to error in calcium metabolism as a result of parathyroid hyperactivity.
In support of this theory, there are reported favorable results from parathy-
roidectomy and from administration of high doses of vitamin D and dihydro-
tachysterol. Parathyroidectomy was first attempted by Beruheim and Garlock
(21) with also reportedly favorable results, but other workers have not been
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able to duplicate them. High dosages of vitamin D was tried by Norman (22)
with apparently good results, but Duryee's (19) report on its use has not been
favorable. Bernstein and Goldberger (23) first tried dthydrotachysterol, but
subsequent reports (24) have not confirmed the report.
If the mere raising of the level of food proteins can reverse the indurative
process, then all the above therapeutic measures as well as the so-called spon-
taneous remissions must be re-examined from the view point of improved dietary
protein intake, either as a result of the inevitable better care taken of cases having
special investigative interest or of improvement in appetite. In this connection,
it is interesting that Becker and Oberrnayer (24) reported good results following
the administration of raw pancreas while O'Leary and Waisman (25) had re-
ported failure with insulin-free pancreatic extracts. Could the difference in the
amount of proteins in these 2 preparations be responsible for this difference in
results?
However, the theory of protein attrition may be an oversimplification. In such
a highly complicated process as is involved in the protein metabolism of tissue
protein building and breakdown there must be a multiplicity of factors: chemical,
enzymatic and endocrine, which must enter into play but of which little is known
or dreamed of at present. This is exemplified in the conjunction of several lines
of thoughts and of experimental and clinical findings weaving together in a still
unexplained way the collagen diseases, cortisone or ACTH, hyperproteinization
and testosterone.
Klemperer et al. (26) in 1941 first applied the term collagen disease to those
conditions in which fibrinoid degeneration was a common feature. These diseases
include rheumatic fever, lupus erythematosus, the allergies, periarteritis nodosa,
Libman-Sack's disease and perhaps scleroderma. Although these authors warned
that the concept was only preliminary and although Duff (27) cautioned that
morphologic similarity did not necessarily signify identity in pathogenesis, the
concept has been further amplied by subsequent workers. Banks (28) added
dermatomyositosis to the category. Masugi and Ya (29) postulated the allergic
basis of scieroderma; and Rich (30) implicated hypersensitivity in periarteritis
nodosa and Evans (31) extended the allergy concept to other collagen diseases.
The report of O'Leary (32) on the favorable effect of the antihistaminic benadryl
on scieroderma advanced the concept considerably.
The advent of cortisone and ACTH has complicated this interrelationship
further. Brodley (33) has reported that ACTH exerts a favorable influence in the
allergic states and Elkington et al (34) that such collagen diseases as acute rheu-
matic fever, lupus erythematosus and dermatomyositis are likewise improved.
This almost constitutes a compelling indication for testing ACTH or cortisone
in scleroderma. On the other hand Herts and Forsham (35) have found testoster-
one also beneficial in soleroderma and it is interesting to note that testosterone
was used in their cases because ACTH was not available.
If the effect of ACTH or cortisone should prove beneficial, as may well
prove to be the case, it will then be necessary to explain why such protein-cata-
bolic agents as these two hormones should be beneficial in a condition in which
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protein-anabolic measures such as hyperproteinization and testosterone are like-
wise beneficial. And the possibility of using anabolic to alternate with catabolic
measures will also arise.
SUMMARY AND CONCLUSIONS
1. A preliminary study of the protein metabolism of 4 cases of scleroderma has
been made.
2. There were no significant laboratory findings to suggest the presence of
protein depletion as it is commonly seen in starvation or following diseases.
3. On a regimen of hyperproteinization, however, there was an extraordinarily
high level of nitrogen deposition, accompanied by huge weight gains indicating
a systemic protein "hunger".
4. Accompanying this N deposition, there are significant softening of the in-
durated areas, healing of the superficial ulcers, increased growth of hair, greater
flexibility of some involved joints, and a feeling of better being and a greater
ability to work.
5. On the basis of these findings, the possibility of there being a third type of
protein depletion—a slow type which may be called protein attrition, is raised
wherein compensatory changes have averted the usual disturbances iji water
metabolism and tissues of inferior quality, i.e., poorer in proteins are deposited.
6. The probability of this hypothesis and its relation to other alleged etiologic
factors is discussed.
7. The probability of the condition being improved also by cortisone and
ACTH was raised.
8. The incidental finding of hyperazoturia in two out of the 4 cases suggests
involvement of the kidneys in the sclerotic process.
9. In three of these cases there was no significant increase in the ratio of stool
nitrogen to intake N which might indicate gross impairment of the absorptive
capacity of the alimentary tract. In one, there was a suggestive increase during
both the control and the hyperproteinization periods.
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